MedTrace Logo

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

NCT05447923 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2026-04-02

No results posted yet for this study

Summary

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Conditions

  • Colorectal Carcinoma

Interventions

OTHER

Educational Intervention

Undergo education for colorectal cancer screening

OTHER

Fecal Immunochemical Test

Undergo FIT testing

BEHAVIORAL

Patient Navigation

Undergo patient navigation for positive FIT results

OTHER

Questionnaire Administration

Complete questionnaire about colorectal cancer screening and healthcare

Sponsors & Collaborators

Principal Investigators

  • Juliana M. Kling, MD, MPH · Mayo Clinic

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-22
Primary Completion
2030-06-01
Completion
2030-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05447923 on ClinicalTrials.gov